Literature DB >> 9620034

Evaluation of a new rapid D-dimer assay for clinically suspected deep venous thrombosis (Liatest D-dimer).

M Escoffre-Barbe1, E Oger, C Leroyer, M Grimaux, E Le Moigne, M Nonent, L Bressollette, J F Abgrall, C Soria, J Amiral, P Ill, J Clavier, D Mottier.   

Abstract

In previous studies, enzyme-linked immunosorbent assays (ELISA) for plasma D-dimer analysis have demonstrated high sensitivity, suggesting their potential usefulness in excluding deep venous thrombosis (DVT). We evaluated the usefulness of a new D-dimer test (Liatest D-dimer) for suspected DVT in a prospective study of patients admitted to the hospital because of recent (not exceeding 1 week before admission) clinical signs. Contrast venography or compression ultrasonography or both were performed within 24 hours of admission. A new quantitative determination of D-dimer concentration using a suspension of microlatex particles coated with specific antibodies was tested. A standard plasma D-dimer ELISA measurement was also performed. Of 464 patients, 276 had a proven DVT (distal, 74; proximal, 202). For a cutoff level of 400 ng/mL, sensitivity of the Liatest method in the diagnosis of overall DVT was 94.6% (95% confidence interval, 92.0%-97.0%), and the specificity was 35% (95% confidence interval, 28%-42%). The sensitivity and negative predictive value were 98.5% and 95.6%, respectively, in the diagnosis of proximal DVT, but only 83.8% and 84.6%, respectively, in the diagnosis of distal DVT. This new rapid Liatest D-dimer assay seems to be highly sensitive and could replace the ELISA method in excluding patients with proximal DVT. Both methods provide lower sensitivity for distal DVT.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620034     DOI: 10.1093/ajcp/109.6.748

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders.

Authors:  Rafael Noal Moresco; Ronald Halla Júnior; Luis Cláudio Rosa Vargas; Lúcia Mariano da Rocha Silla
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

Review 2.  D-dimer testing: the role of the clinical laboratory in the diagnosis of pulmonary embolism.

Authors:  B H Mavromatis; C M Kessler
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

Review 3.  Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review.

Authors:  Tonya L Fancher; Richard H White; Richard L Kravitz
Journal:  BMJ       Date:  2004-09-21

4.  D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems.

Authors:  Rafael Noal Moresco; Luis Cláudio Rosa Vargas; Carlos Franco Voegeli; Roberto Christ Vianna Santos
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

5.  Estimation of the levels of D-dimer by use of an alternative method based in the reaction time of fibrinogen/fibrin degradation products assay.

Authors:  Rafael Noal Moresco; Luis Cláudio Rosa Vargas; Lúcia Silla
Journal:  J Thromb Thrombolysis       Date:  2006-12-09       Impact factor: 5.221

6.  Clotting state after cardioversion of atrial fibrillation: a haemostasis index could detect the relationship with the arrhythmia duration.

Authors:  Eleni Hatzinikolaou-Kotsakou; Zafirios Kartasis; Dimitrios Tziakas; Dimitrios Stakos; Athanasios Hotidis; Georgios Chalikias; Georgios Bourikas; Dimitrios I Hatseras
Journal:  Thromb J       Date:  2005-03-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.